Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $558.6600 (4.28%) ($538.0050 - $559.3000) on Fri. Dec. 4, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.59% (three month average) | | RSI | 56 | | Latest Price | $558.6600(4.28%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.2% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | | Factors Impacting REGN price | REGN will decline at least -1.295% in a week (0% probabilities).
VIXM(-14%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.295% (StdDev 2.59%) | | Hourly BBV | 0 () | | Intraday Trend | 3.8% | | | | | |
|
| 1 - 5 Day Possible Target | $546.94(-2.1%) | | Resistance Level | $560.98 | | 5 Day Moving Average | $546.3(2.26%) | | 10 Day Moving Average | $556.76(0.34%) | | 20 Day Moving Average | $560.98(-0.41%) | | To recent high | -4.8% | | To recent low | 23.6% | | Market Cap | $59.234b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |